Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Safety and efficacy of mesenchymal stromal cells mitochondria transplantation as a cell-free therapy for osteoarthritis

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Contributors:
      Universidad de los Andes Santiago (UANDES); Pontificia Universidad Católica de Valparaíso (PUCV); Universidad de Concepción = University of Concepción Chile (UdeC); Universidad Católica de Temuco (UCT); Universidad San Francisco de Quito (USFQ); Universidad Católica de la Santísima Concepción (UCSC); Universidad San Sebastian = San Sebastian University Santiago, Chile (USS); Pontificia Universidad Católica de Chile (UC); Hospital Clínico Universidad de Chile; Universidad Central de Chile; Universidad San Sebastian; Cellules Souches, Plasticité Cellulaire, Médecine Régénératrice et Immunothérapies (IRMB); Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM); Hôpital Saint Eloi CHU Montpellier; Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier); Service de Rhumatologie CHU de Montpellier; CHU Montpellier
    • Publication Information:
      CCSD
      BioMed Central
    • Publication Date:
      2025
    • Collection:
      Université de Montpellier: HAL
    • Abstract:
      International audience ; Objective: The inflammatory responses from synovial fibroblasts and macrophages and the mitochondrial dysfunction in chondrocytes lead to oxidative stress, disrupt extracellular matrix (ECM) homeostasis, and accelerate the deterioration process of articular cartilage in osteoarthritis (OA). In recent years, it has been proposed that mesenchymal stromal cells (MSC) transfer their functional mitochondria to damaged cells in response to cellular stress, becoming one of the mechanisms underpinning their therapeutic effects. Therefore, we hypothesize that a novel cell-free treatment for OA could involve direct mitochondria transplantation, restoring both cellular and mitochondrial homeostasis.Methods: Mitochondria were isolated from Umbilical Cord (UC)-MSC (Mito-MSC) and characterized based on their morphology, phenotype, functions, and their ability to be internalized by different articular cells. Furthermore, the transcriptional changes following mitochondrial uptake by chondrocytes were evaluated using an Affymetrix analysis, Lastly, the dose dependence therapeutic efficacy, biodistribution and immunogenicity of Mito-MSC were assessed in vivo, through an intra-articular injection in male C57BL6 mice in a collagenase-induced OA (CIOA) model.Results: Our findings demonstrate the functional integrity of Mito-MSC and their ability to be efficiently transferred into chondrocytes, synovial macrophages, and synovial fibroblasts. Moreover, the transcriptomic analysis showed the upregulation of genes involved in stress such as DNA reparative machinery and inflammatory antiviral responses. Finally, Mito-MSC transplantation yielded significant reductions in joint mineralization, a hallmark of OA progression, as well as improvements in OA-related histological signs, with the lower dose exhibiting better therapeutic efficacy. Furthermore, Mito-MSC was detected within the knee joint for up to 24 h post-injection without eliciting an inflammatory response in CIOA mice.Conclusion: Collectively, our ...
    • Relation:
      info:eu-repo/semantics/altIdentifier/pmid/39773289; PUBMED: 39773289; PUBMEDCENTRAL: PMC11706173
    • Accession Number:
      10.1186/s12967-024-05945-7
    • Online Access:
      https://hal.science/hal-04941174
      https://hal.science/hal-04941174v1/document
      https://hal.science/hal-04941174v1/file/12967_2024_Article_5945.pdf
      https://doi.org/10.1186/s12967-024-05945-7
    • Rights:
      http://creativecommons.org/licenses/by-nc-nd/ ; info:eu-repo/semantics/OpenAccess
    • Accession Number:
      edsbas.3F2458F3